James Condulis
Stock Analyst at Stifel
(2.92)
# 1,672
Out of 4,920 analysts
5
Total ratings
75%
Success rate
23.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $21.71 | +102.67% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $81.63 | +32.30% | 2 | Mar 28, 2025 | |
| CYTK Cytokinetics | Initiates: Buy | $80 | $36.14 | +121.36% | 1 | Jan 22, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $13.74 | +118.34% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $21.71
Upside: +102.67%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $81.63
Upside: +32.30%
Cytokinetics
Jan 22, 2025
Initiates: Buy
Price Target: $80
Current: $36.14
Upside: +121.36%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $13.74
Upside: +118.34%